108
Views
43
CrossRef citations to date
0
Altmetric
Research Article

Successful Treatment with Erwinia l -Asparaginase for Recurrent Natural Killer/T Cell Lymphoma

, , , , , , , , , , & show all
Pages 879-882 | Published online: 01 Jul 2009

  • Cheung, M.M., Chan, J.K., Lau. W.H. Foo. W., Chan, P.T., Ng. C.S. and Ngan, R.K. (1998) "Primary non-Hodgkin's lymphorma of the nose and nasopharynx: clinical features, tumor immunophenotype, and treatment outcome in 113 patients", Journal of Clinical Oncology 16, 70-77.
  • Chan, J.K., Sin, V.C., Wong, K.F, Ng. C.S., Tsang. W.Y. Chan. C.H. Cheung. M.M. and Lau. W.H. (1997) "Nonnasal lymphoma expressing the natural killer cell marker CD56: a clinicopathologic study of 49 cases of an uncommon aggressive neoplasm", Blood 89. 4501-4513.
  • Kwong, Y.L., Chan. A.C. Liang, R. Chiang, A.K., Chim. C.S., Chan, T.K. Todd. D. and Ho, F.C. (1997) "CD56+ NK lymphomas: clinicopalhological features and prognosis", British Journal of Haematology 97, 821-829.
  • Nagafuji, K, Fujisaki, T., Arima, F. and Ohshinia. K. (2001) "L,-asparaginase induced durable remission of relapsed nasal NK/ T-cell lymphoma after autologous peripheral blood stem cell transplantation", International Journal of Hematology 74. 447-450.
  • Story, M.D., Voehringer, D.W., Stephens. L.C. and Meyn. R.E. (1993) "L-asparaginase kills lymphoma cells by apoptosis", Cancer Chemotherapy and Pharmacology 32, 129-133.
  • Ueno, T., Ohtawa, K., Mitsui'. K., Kodera. Y. Hiroto, M., Matsushima. A., lnada. Y and Nishimura. H. (1997) "Cell cycle arrest and apoptosis of leukemia cells induced by L-asparaginase", Leukemia II. 1858-1861.
  • Kitoh, T., Shibata, M., Sawada. M., Nakayama. H., lshii. E., Hyakuna, N. Nakabata, T. and Schuster. S.M. (2001) "NK related antigen positive leukemia with low expression of asparaginase synthetase: a group of leukemia clinically sensitive to L-asparaginase", Expermental Hematology 29, 25.
  • den Boer, M.L., Pieters, R., Kazemier. K.M., Rottier. K.M., Zwaan. C.M., Kaspers. G.J. Janka-Schaub, G., Henze, G., Creutig. U., Schcper, R.J. and Veerman. A.J. (1998) "Relationship between major vault protein/lung resistance protein, multidrug resistanceassiociated protein. P-glyeoprotein expression, and drug resistance in childhood leukemia", Blood 91, 2092-2098.
  • Pieters, R., Hongo, T., Loonen, A.H., Huismans. D.R., Broxterman, H.J., Hahlen, K. and Veerman. A.J. (1992) "Different types of nonP-glycoprotein mediated multiple drug resistance in children with relapsed acute lymphoblastic leukaemia", British Journal of Cancer 65, 691-697.
  • Haskell, C.M. Canellos, G.P. Leventhal, B.C., Carbone. P.P., Block, J.B., Serpick, A.A. and Selawry. O.S. (1969) "L-asparaginase: therapeutic and toxic effects in patients with neoplaslic disease", The New England Journal of Medicine 281, 1028-1034.
  • Evans, W.E., Tsiatis. A., Rivera, G., Murphy, S.B., Dahl, G.V., Denison, M., Crom, W.R., Barker, L.F and Mauer. A.M. (1982) "Anaphyiactoid reactions to Escherichia coli and Erwinia asparaginase in children with leukemia and lymphoma", Cancer 49, 1378-1383.
  • Oettgen, H.K. Stephenson. P.A., Schwartz, M.K., Leeper, R.D., Tallai, L., Tan, C.C., Clarkson, B.D., Golbey, R.B., Krakoff, I.H., Kamofsky, D.A., Murphy, M.L. and Burchenal, I.H. (1970) "Toxicity of E. coli L-asparaginase in man", Cancer 25, 253-257.
  • Billed, A.L., Carls, A., Gelber, R.D. and Sallan, S.E. (1992) "Allergic reactions to Envinia asparaginase in children with acute lymphoblastic leukemia who had previous allergic reactions to Escherichia coli asparaginase", Cancer 70, 201-206.
  • Dellinger, C.T. and Miale. T.D. (1976) "Comparison of anaphylactic reactions to asparaginase derived from Esrherichia coIi and from Erwintia cultures", Cancer 38, 1843 -1846.
  • Pralt, C.B., Choi. S.I. and Holton, C.P. (1971) "Low-dosage usparaginase treatment of childhood acute lymphocytic leukemia", American Journal of Diseases of Children 121. 406-409.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.